Home > Boards > US Listed > Biotechs > Opko Health Inc (OPK)

The diet drug fits Pfizer's pipeline pretty well.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Femto99 Member Profile
Member Level 
Followed By 43
Posts 4,142
Boards Moderated 10
Alias Born 02/22/18
160x600 placeholder
OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health ... PR Newswire (US) - 1/13/2021 3:40:00 PM
Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q’20 Guidance GlobeNewswire Inc. - 1/13/2021 6:00:00 AM
OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 1/5/2021 8:00:00 AM
OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide PR Newswire (US) - 1/4/2021 12:05:00 PM
Pfizer, OPKO: FDA to Review Somatrogon for Growth-Hormone Deficiency Dow Jones News - 1/4/2021 9:09:00 AM
US FDA Accepts Regulatory Submission from Pfizer & OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Horm... Business Wire - 1/4/2021 6:45:00 AM
Buffalo Bills and OPKO Health's BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Prog... PR Newswire (US) - 12/31/2020 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/29/2020 7:34:20 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2020 8:09:54 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/21/2020 8:07:23 AM
OPKO Health Appoints Dr. Roger Medel to its Board of Directors GlobeNewswire Inc. - 12/21/2020 8:00:00 AM
Sian Capital Sends Letter to OPKO Health Regarding its Decision to Apparently Withhold Rayaldee From Many Patients Amidst COV... GlobeNewswire Inc. - 11/20/2020 4:45:00 PM
Sian Capital Issues Open Letter to Stockholders of OPKO Health GlobeNewswire Inc. - 11/12/2020 6:30:00 PM
OPKO Health to Participate in Three Upcoming Investment Conferences GlobeNewswire Inc. - 11/11/2020 9:10:51 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/2/2020 6:57:26 AM
Sian Capital Highlights Paths to Meaningful Value Creation at OPKO Health GlobeNewswire Inc. - 10/29/2020 5:20:36 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/29/2020 4:26:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/29/2020 4:08:24 PM
OPKO Health Reports 2020 Third Quarter Business Highlights and Financial Results GlobeNewswire Inc. - 10/29/2020 4:05:10 PM
OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test PR Newswire (US) - 10/20/2020 8:00:00 AM
OPKO Health to Report Third Quarter 2020 Financial Results on October 29, 2020 GlobeNewswire Inc. - 10/13/2020 12:50:49 PM
OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools PR Newswire (US) - 10/9/2020 8:00:00 AM
Notice of Class Action Settlement Involving Purchasers of OPKO Health, Inc. Common Stock during the period of September 26, 2... PR Newswire (US) - 10/8/2020 9:08:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/15/2020 10:32:13 AM
OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients GlobeNewswire Inc. - 9/15/2020 7:00:10 AM
Femto99 Member Level  Thursday, 09/17/20 07:32:12 PM
Re: tredenwater2 post# 12596
Post # of 14347 
The diet drug fits Pfizer's pipeline pretty well. Lily dropped it because they already have something to treat type II diabetes.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences




Ticker News is disabled